WUHAN, China, July 25, 2025 /PRNewswire/ -- GeeTest, a global leader in bot mitigation and business security, has released its 2025 E-commerce Industry Security...
The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of...
The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of...
The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses,...
The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses,...
GRENOBLE, France, July 24, 2025 /PRNewswire/ -- Stellaria, a French start-up originating from CEA and Schneider Electric, has announced that it has raised a...
MN-166 COMBAT ALS trial down to single digit required enrollment while MN-001 hypertriglyceridemia trial in type 2 diabetes patients requires final two patients
MN-166 COMBAT ALS trial down to single digit required enrollment while MN-001 hypertriglyceridemia trial in type 2 diabetes patients requires final two patients
Organization to Participate in 12 National Events as Part of Innovative Health Education Initiative
WASHINGTON, July 24, 2025 /PRNewswire/ -- LUNGevity Foundation, the nation's leading...
KUALA LUMPUR, Malaysia, July 24, 2025 /PRNewswire/ -- DOBOT Robotics officially announces the grand opening of its Malaysia subsidiary, marking a key milestone in...
TAIPEI, July 24, 2025 /PRNewswire/ -- As surging demand threatens to fragment the supply chain into costly proprietary silos, the Open Compute Project, an...